Skip to content
OpenCapital
Get started

STERIS STE Free cash flow

Free cash flow at other companies

Ecolab logo
EcolabECL
$97.4M-25.9%
3M logo
3MMMM
$349M+211%
Stryker logo
StrykerSYK
$415M+227%
Mesa Laboratories logo
Mesa LaboratoriesMLAB
$13.55M+13.7%
Boston Scientific logo
Boston ScientificBSX
$171M-51.7%
IAR
Integra LifeSciencesIART
-$5.05M+87.4%

Other financials

Income statement

See full
Revenue$1.6B+7.3%
Gross profit$697.2M+8.8%
Operating income$316.8M+46.6%
Net income$220.2M+51.2%
EPS (diluted)$2.24+52.4%

Balance sheet

See full
Cash & equivalents$439.6M+156%
Total debt$2.1B-10.3%
Total equity$7.2B+8.8%
Total assets$10.7B+5.8%

Cash flow

See full
Operating cash flow$335.4M+28.6%
CapEx$90.2M+27.2%

Valuation

See full
Market cap$20.52B-9.4%
Enterprise value$22.17B-8.8%
P/E26.2×-8.8×
P/S3.5×-0.6×

Profitability

See full
Gross margin44.2%+0.2pp
Operating margin18.6%+2.7pp
Net margin13.2%+1.9pp
FCF margin16.4%+2.1pp

Returns & leverage

See full
Return on equity11.3%+1.8pp
Debt / equity0.3×-0.1×
Current ratio2.1×+0.1×

Where this comes from

Calculated from STERIS’s reported figures.

$335.4Mnet cash from operating−$90.2Mcapital expenditures=$245.2M

The official record: STERIS’s 10-K, filed May 29, 2026, on SEC EDGAR. View the filing →

Ask your AI about STERIS's free cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is STERIS's free cash flow?
STERIS (STE) reported free cash flow of $245.2M in Q1 2026.
How has STERIS's free cash flow changed year-over-year?
STERIS's free cash flow increased by 29.1% year-over-year, from $189.9M to $245.2M.
What is the long-term trend for STERIS's free cash flow?
Over 4 years (2022 to 2026), STERIS's free cash flow has grown at a 25.1% compound annual growth rate (CAGR), from $397.25M to $972.4M.
What does free cash flow mean?
Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and maintain or expand its capital asset base. It serves as a critical indicator of a company's ability to fund organic growth, pay down debt, or return capital to shareholders without relying on external financing.